Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches
使用单细胞方法解决精神疾病基因的复杂选择性剪接
基本信息
- 批准号:10630216
- 负责人:
- 金额:$ 75.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-05 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdultAffectAlternative SplicingAmericanAutopsyBipolar DisorderBrainBrain DiseasesCatalogsCell CommunicationCell modelCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDevelopmentDiagnosticEngineeringExhibitsExonsExperimental DesignsFailureGenesGenetic VariationGenetic studyGenotypeGlutamatesGoalsHumanImpairmentInduced pluripotent stem cell derived neuronsLengthMapsMental disordersNeurodevelopmental DisorderNeuronsOrganoidsPatternPhenotypePhysiologicalProsencephalonProtein IsoformsQuantitative Trait LociRNA SplicingResearchResolutionSchizophreniaSynapsesTechnologyTissuesWorkautism spectrum disorderbrain tissuecell typeclinical predictorsdifferential expressionfetalimprovedinduced pluripotent stem cellmind controlmutantneural circuitneuropsychiatric disordernovelnovel therapeutic interventionoverexpressionpredict clinical outcomerisk variantschizophrenia risksingle cell sequencingstandard caresynaptic functiontargeted sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Schizophrenia (SZ), bipolar disorder (BD) and autism spectrum disorder (ASD) are common and debilitating
neurodevelopmental disorders that together affect more than 5 million Americans. Despite more than fifty years
of research, no cures exist and the standard of treatment remains unsatisfactory. Dysregulation of alternative
splicing in the human brain has been implicated in SZ. Among genes with critical brain functions, many have a
large number of exons, resulting in complex splicing patterns that can vary between neuronal subtypes;
however, the isoform repertoires of most of these complex genes have not been resolved in a cell-type specific
manner. Recent advances in long read sequencing have provided an unprecedented opportunity to resolve
complex alternative splicing. Thus, to better understand the clinical impact of changes of alternative splicing in
psychiatric diseases, it is critical to evaluate how isoform repertoire impact neuronal maturation and synaptic
function in a cell-type specific manner. Here, we propose to catalog and functionally characterize the
complexity of human isoform repertoires of SZ-associated genes using a single-cell long-read sequencing
based approach, and to study how genetic variations influence alternative splicing and impact neuronal
maturation and synaptic function in a subtype specific manner. This project will provide comprehensive
catalogs of cell-specific full isoform repertoires of SZ genes that will broadly facilitate SZ research. It will also
deepen the understanding of how genetic variations and alternative splicing contribute to SZ, help better
predict the clinical outcome and identify novel therapeutic interventions. The single cell approach used in this
project is generally applicable to study other mental disorders such as BD and ASD.
项目摘要
精神分裂症(SZ),躁郁症(BD)和自闭症谱系障碍(ASD)是常见的,使人衰弱
神经发育障碍共同影响超过500万美国人。尽管超过五十年
在研究中,不存在治疗方法,并且治疗标准仍然不令人满意。替代方案的失调
人脑中的剪接与SZ有关。在具有关键大脑功能的基因中,许多人具有
大量外显子,导致复杂的剪接模式在神经元亚型之间变化;
但是,这些复杂基因中大多数的同工型库尚未在细胞类型的特异性中解析
方式。长期阅读测序的最新进展为解决方案提供了前所未有的机会
复杂的替代剪接。因此,更好地了解替代剪接变化的临床影响
精神病疾病,评估同工构曲目如何影响神经元成熟和突触是至关重要的
以细胞类型的特定方式功能。在这里,我们提议分类并在功能上表征
使用单细胞长读测序的SZ相关基因的人类同工型曲目的复杂性
基于基于的方法,并研究遗传变异如何影响替代剪接和影响神经元
以亚型特异性方式成熟和突触函数。该项目将提供全面
SZ基因的细胞特异性全同工型库的目录,这些基因将广泛促进SZ研究。它也会
加深对遗传变异和替代剪接对SZ的贡献的理解,帮助更好
预测临床结果并确定新的治疗干预措施。在此使用的单个单元方式
项目通常适用于研究其他精神疾病,例如BD和ASD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristen Jennifer Brennand其他文献
Kristen Jennifer Brennand的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristen Jennifer Brennand', 18)}}的其他基金
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes
神经精神和神经发育障碍风险基因的高通量体内和体外功能和多组学筛选
- 批准号:
10643398 - 财政年份:2023
- 资助金额:
$ 75.69万 - 项目类别:
Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traits
模拟生理和环境压力源对精神特征常见变异的相互作用
- 批准号:
10706811 - 财政年份:2022
- 资助金额:
$ 75.69万 - 项目类别:
Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traits
模拟生理和环境压力源对精神特征常见变异的相互作用
- 批准号:
10337629 - 财政年份:2021
- 资助金额:
$ 75.69万 - 项目类别:
Resolving complex alternative splicing of psychiatric disease genes using single-cell approaches
使用单细胞方法解决精神疾病基因的复杂选择性剪接
- 批准号:
10462568 - 财政年份:2021
- 资助金额:
$ 75.69万 - 项目类别:
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
健康老龄化和阿尔茨海默病脑细胞 DNA 腺嘌呤甲基化的批判性评估
- 批准号:
10365337 - 财政年份:2021
- 资助金额:
$ 75.69万 - 项目类别:
Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders
与神经发育障碍相关的多种基因被破坏后的功能趋同
- 批准号:
10626945 - 财政年份:2021
- 资助金额:
$ 75.69万 - 项目类别:
Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders
与神经发育障碍相关的多种基因被破坏后的功能趋同
- 批准号:
10407989 - 财政年份:2021
- 资助金额:
$ 75.69万 - 项目类别:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
新的网络生物学方法重新定位 FDA 批准的阿尔茨海默病药物
- 批准号:
10653036 - 财政年份:2020
- 资助金额:
$ 75.69万 - 项目类别:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
新的网络生物学方法重新定位 FDA 批准的阿尔茨海默病药物
- 批准号:
10260473 - 财政年份:2020
- 资助金额:
$ 75.69万 - 项目类别:
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
新的网络生物学方法重新定位 FDA 批准的阿尔茨海默病药物
- 批准号:
10451659 - 财政年份:2020
- 资助金额:
$ 75.69万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 75.69万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 75.69万 - 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 75.69万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 75.69万 - 项目类别: